Prevalence of anaemia in pregnant women (aged 15-49) in Kyrgyzstan
Kyrgyzstan: Prevalence of anaemia in pregnant women (aged 15-49) was 20.6% in 2019. ▲ Rising
Prevalence of anaemia in pregnant women (aged 15-49) in Kyrgyzstan, 2000–2019
Source: World Health Organization, Global Health Observatory.
Analysis
In 2019, prevalence of anaemia in pregnant women (aged 15-49) in Kyrgyzstan stood at 20.6%. That is the highest value across all 20 years on record.
That represents a change of up 3.0% over ten years.
Over the whole period, prevalence of anaemia in pregnant women (aged 15-49) in Kyrgyzstan peaked at 20.6% in 2018 and was at its lowest, 19.5%, in 2000.
That places Kyrgyzstan 60th out of 194 countries with data for 2019, putting it in the middle of the range.
The long-run direction has been consistently rising across the 20 years of available data.
Prevalence of anaemia in pregnant women (aged 15-49) in Kyrgyzstan, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 19.5% | — |
| 2001 | 19.6% | +0.5% |
| 2002 | 19.6% | +0.0% |
| 2003 | 19.7% | +0.5% |
| 2004 | 19.7% | +0.0% |
| 2005 | 19.8% | +0.5% |
| 2006 | 19.9% | +0.5% |
| 2007 | 19.9% | +0.0% |
| 2008 | 19.9% | +0.0% |
| 2009 | 20.0% | +0.5% |
| 2010 | 20.0% | +0.0% |
| 2011 | 20.0% | +0.0% |
| 2012 | 20.2% | +1.0% |
| 2013 | 20.2% | +0.0% |
| 2014 | 20.4% | +1.0% |
| 2015 | 20.5% | +0.5% |
| 2016 | 20.5% | +0.0% |
| 2017 | 20.5% | +0.0% |
| 2018 | 20.6% | +0.5% |
| 2019 | 20.6% | +0.0% |
Kyrgyzstan compared with similar countries
- Kyrgyzstan's 20.6% is below the median for lower middle income countries, which is 22.9%, 90% of the median. (47 countries reporting)
- Kyrgyzstan's 20.6% is above the median for Europe & Central Asia, which is 13.6%, 1.5× the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 19.8% | 19.5% | 20.0% | 10 |
| 2010s | 20.4% | 20.0% | 20.6% | 10 |
Countries ranked near Kyrgyzstan
- 57 Eritrea 20.8% compare
- 58 South Sudan 20.7% compare
- 58 Malawi 20.7% compare
- 60 Uzbekistan 20.6% compare
- 60 Jordan 20.6% compare
- 60 Micronesia (country) 20.6% compare
More gender data for Kyrgyzstan
- Child population (UN estimates and projections) 2,300 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.5338 % change on previous year (2030)
- Population 5,504 (2030)
- Working-age population (UN estimates and projections) 5,504 (2030)
- Population (UN estimates and projections), annual growth rate 2.06 % change on previous year (2030)
- Age population, age 00, female, interpolated 72,260 (2025)
- Age population, age 00, male, interpolated 76,154 (2025)
- Age population, age 01, female, interpolated 72,405 (2025)
- Age population, age 01, male, interpolated 76,252 (2025)
- Age population, age 02, female, interpolated 72,315 (2025)
Frequently asked questions
- What is prevalence of anaemia in pregnant women (aged 15-49) in Kyrgyzstan?
- Prevalence of anaemia in pregnant women (aged 15-49) in Kyrgyzstan was 20.6% in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest prevalence of anaemia in pregnant women (aged 15-49) recorded in Kyrgyzstan?
- The highest recorded value was 20.6% in 2018.
- What is the lowest prevalence of anaemia in pregnant women (aged 15-49) recorded in Kyrgyzstan?
- The lowest recorded value was 19.5% in 2000.
- How does Kyrgyzstan rank for prevalence of anaemia in pregnant women (aged 15-49)?
- Kyrgyzstan ranks 60th out of 194 countries with data for 2019.
- Is prevalence of anaemia in pregnant women (aged 15-49) rising or falling in Kyrgyzstan?
- Over the last ten years it is up 3.0%. The long-run trend across the full record is rising.
- Where does this Kyrgyzstan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Prevalence of anaemia in pregnant women (aged 15-49) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).